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The contribution of drugs and toxins 
to understanding of cholinergic 
function 
THE USE OF DRUCS and toxins for the analysis of nervous system 
function is over 100 years old. It considerably predates the general 
acceptance of the theory of chemical transmission at synapses, and 
indeed provided much of the evidence that led to the formulation of 
the theory. Studies with drugs and toxins have since helped to 
elucidate the detailed mechanisms of neu~~smission, and to 
classify receptor types and 
subtypes. The first terminal to 
be examined in d&all in this 
way was the dlolinergic nerve 
terminal. 
The cholinergic nerve terminal 
Figure 1 shows the currently 
accepted view of the organization 
of the cholinergic neurone’. 
Briefly, acetylcholine is syn- 
thesized from choline and acetyl- 
coenzyme A in the terminal cyto- 
plasm by the soluble cytoplasmic 
enzyme choline acetyltransferase; 
it leaks out in a non-quantized 
fashion at a rate that at rest greatly 
exceeds the spontalieous quan- 
tized release from vesicles but 
does not increase significantly on 
stim~ation. By contrast, stimu- 
lation greatly increases quantized 
(vesicular) release and generates, 
from the reserve vesicle popu- 
lation, an actively recycling pool 
which replenishes itself from the 
cytoplasmic pool. 
Ace~lcholine released in either 
quantized or non-quantized form 
after interaction with receptors is 
rapidly hydrolysed by acetyl- 
cholinesterase to acetate and 
choline. Choline, and probably 
acetate are reurii&d. Choline is 
taken up by a high affinity trans- 
port system and reacetylated to 
acetylcholine which then again 
becomes available for vesicular 
uptake. At rest, after stimulation, 
recycling vesicles become fully 
charged with transmitter and join 
the reserve‘ pooi. Transmitter 
release is highly regulated by 
negative-feedback loops (Fig. 1). 
Evidence for this model has 
been amassed in two waJs: by 
subcei!ular fractionation2 ; and 
by the use of drugs and toxins that 
selectively interact, as agonists, 
antagonists or blocking agents at 
various points in the process (Fig. 
1; Table 1). Such substances have 
been of great importance in dis- 
secting out the various steps in 
the synthesis, &rage and release 
of acetylch&ne, and this in turn 
has led to a better understanding 
of the mode of action of drugs and 
toxins on the cholinergic system 
and the development of rational 
therapies and antidotes. 
Receptor agonists and antagonists 
The first drugs used to investi- 
gate neurotransmission were 
naturally occurring toxins that 
interact with the acetylcholine 
receptor. 
Curare 
The great French physiologist 
Claude Bernard carried out the 
first physiological investigation of 
the South American arrow poisun 
curare, the main active principle 
of which is rr-tubocurarine. 
Bernard showed that curare 
blocked neuromuscular transmis- 
sion in the frog without affecting 
the excitability of either the motor 
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nerve or the muscle and thereby 
correctly concluded that the site of 
action was the junction between 
them. 
CIaude Bernard (1813-1878) was 
one of the most remarkable men of 
his day. Of humble origins, he 
managed to qualify in medicine 
but never practised: he devoted 
himself to physiological research 
at considerable personal and 
financial sacrifice at a time when 
scientific research was not re- 
garded as a full-time profession. 
He was a pupil of Magendie who 
discovered the ‘law of the spinal 
roots’ which stated that afferent 
nerve fibres entered the spinal 
cord through the dorsal roots, 
whereas the efferent fibres left 
through the ventral. Bernard 
eventually obtained the Professor- 
ship in Physiology at the Sor- 
bonne and membership of the 
Academy. He made important 
contributions to our knowledge of 
digestion and liver function and 
introduced the concept of the con- 
stancy of the ‘milieu int&ieur’ 
(interior environment) which was 
later developed by the American 
physiologist W. 8. Cannon in his 
concept of homeostasis. 
His personal life was less suc- 
cessful. He married a well-to-do 
widow who sympathized more 
with the animals he operated on 
than with her husband’s scientific 
achievements - perhaps with 
some justi~cation, since curariz- 
ation was used by Bernard and 
others as a form of anaesthesia. 
The realization by British physi- 
ologists that this was unjustified 
led to the world’s first legal regu- 
lation of animal experimentation 
by the British parliament (Creels 
to Animals Act, 1876). 
The discovery of the action of 
curare on the neuromuscular 
junction did not lead immediately 
TABLE I. Sites of action of drugs and toxins that affect ~olinergi~ n~~tran~ission 
Ceiiuiar iocaticn Functional component Specific inhibitors 
Presynaptic plasma choline transporter hemichoiinium; choline mustard 
membrane aziridinium 
Presynaptic Wminai cylosol choline acetyl transferase naphthyimethyipyridinium 
Recycling synaptic vesicles acetykhoiine transporter vesamicoi 






Synaptic cleft acetylchoiinesterase carbamates; organo- 
phosphates; acetyi- 
choline anatogues 
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to the concept of chemical trans- 
mission - 60 or more years would 
pass before scientific opinion was 
ready for that - but it is worth 
mentioning that it was the dis- 
covery of the analogous action of 
strychnine in specifically blocking 
inhibitory synaptic action in the 
spinal cord that so impressed 
Eccles and led him to accept the 
concept of chemical transmission 
in the CNS. 
Nicotitze and the lnicotinic 
acetylcholiue receptor 
The alkaloid nicotine is respon- 
sible for much of the physiological 
response to smoking - particularly 
the hyperglycaemia with its atten- 
dant sense of well-being. Tobacco 
(Fig. 2) was first grown in France 
as the result of the initiative of the 
French ambassador to Portugal, 
Jean Nicot, who sent seeds to 
France in 1550. The plant received 
the systematic name ~~c~tj~n~ 
fabacu~ after Nicot; nicotine was 
first isolated in pure form in 1828 
and was synthesized in 1904. 
The Cambridge (UK) physi- 
ologist Langley found that, when 
painted on autonomic ganglia, 
nicotine first stimulated, then 
blocked them. This property en- 
abled him to work out the anat- 
omy of the autonomic nervous 
system, and led to the recognition 
of one large class of acetylcholine 
receptors as nicotinic. These 
resolve into a number of sub- 
classes: decamethonium is an ex- 
cellent blocking agent at the type 
of nicotinic receptor at the neuro- 
muscular junction; hexamethon- 
ium is not effective at this junc- 
tion but blocks transmission in 
autonomic ganglia. 
For many decades the nicotinic 
acetylcholine receptor was a 
pharmacological and physio- 
logical hypothesis: a ligand- 
gated channel with permeability 
to univalent cations. The isolation 
of a-bungarotoxin from the venom 
of the banded krait, ~ifngarus 
multicincfus (Fig. 2) by the Tai- 
wanese biologist Lee4 and his 
demonstration that it specifically 
blocked nicotinic receptors with a 
very high affinity gave neuro- 
chemists for the first time a handle 
with which to isolate and charac- 
terize the receptor. 
a-Bungarotoxin itself has too 
high an affinity to be useful, but 
Edith Heilbronn and her col- 









fig. 1. Scheme showing in simplified form the currenf vfew of the organization of the 
ch~i~a~fc nerve ferli;iRal, t&s fu~tio~af proteins in~iv~ end the sites where specific 
tfgands interact. Choline (Ch) is taken up by a h@h affinity transporter and acetylated by 
choline acetyitransferase (CAAT), to produce acetylchotine (ACA) which is then taken 
up into recycling vesicles. Spontaneous or stimulus-induced quanta! release involves 
the exocytosis of vesicles and the release of ACh into the cleft. Here it interacts with 
nicotinic (nAChR) or muscarinic (mAChR) acetyfcholine receptors depanding on the 
type of target cell and is then broken down by acefylcholinesterase (ACRE). The choline 
(Ch) so reteased is salvaged by the choline transporter. Activation of presynaptic 
mAChf?s can sfow ACh release. Inhibitors: HC-3, hem~hofinium-3; NVP, naphtha- 
me#ylpy~i~fum: ONB, quinuclidine crate; ruBTx, ~-bungarotoxin: dTC, 
o-tubocurarfne. 
similar venom from the cobra, 
ated, had the right affinity to 
provide the basis for the purifi- 
Naja naja, especially when acetyl- 
cation of the receptor by affinity 
chromatography. In an attempt to 
raise an antibody to the newly 
_. 
isolated receptor protein, Heil- 
bronn and Mattssor6 observed - 
as Patrick and Lindstrom7 in- 
dependently observed at about 
the same time - the hind-limb 
paralysis now designated exper- 
imental autoimmune myasthenia 
gravis. 
Subsequent work by many 
groups has led to a detailed 
knowledge of the structure of the 
receptor. A notable contribution 
has been the cloning and sequenc- 
ing of cDNA encoding its four 
constituent 
t: 
olypeptides by the 
Numa group . 
Another historically important 
Muscarine aud the rnuscarinic 
alkaloid is muscarine, the toxic 
principle of the intensely poison- 
ous mushroom Amnnita muscaria 
acefylcholine receptor 
or fly-agaric (Fig. 2). This alkaloid 
excites, and then blocks a different 
__ 
type of cholinergic synapse: that 
of the paras~pathetic endings in 
smooth muscle and glands. All its 
effects are reversed by atropine, 
the toxic alkaloid of Atropa belIa- 
dor~n or deadly nightshade (Fig. 
2). Urged on by a Swedish pro- 
fessor of pharmacology who as- 
sured nie I would not exceed the 
threshold dose, ! once ate several 
berries and found them sweet and 
delicious; this may explain the 
tendency of children to eat them 
and to be poisoned by them. 
More recently, muscarinic 
1 











fig. 2. Sourws of toxins that affect cbofinetgfc function. The tobacco plant Nicotiniana 
tabacum, source of nicotine. The banded krait Bungarus multicinctus, SOUIW of (Y- 
bungarotoxin. Deadly nightshade, Atropa belladonna, source of atropine. Fly-agaric, 
Amanita muscaria, a bright/y wloured toxic fungus, the source of muscarine. 
receptors have been found in the 
CNS and, presynaptically, in some 
types of cholinergic terminal where 
they form part of a negative-feed- 
back loop regulating the release of 
the transmitter (Fig. 1). Three 
subtypes can be distinguished 
pha~aco~ogic~ly. A vast number 
of muscarinic ligands are now 
known; more than 90 are listed in 
the 10th edition of the Merck 
Index, among them the quinucli- 
dines. Molecular geneticists have 
recently succeeded in uncovering 
several more subtypes hitherto 
unknown to pharmacologists and 
these offer the possibility of very 
precise targeting of muscarinic 
drugs. 
The concept of chemical 
transmission 
The ability of muscarine to 
mimic parasympathetic stimu- 
lation parallels that of adrenaline 
to mimic sympathetic stimulation. 
These resemblances led Elliot in 
l9O49 and Dixon in 1906” to 
postulate that endogenous ligands 
identical or similar to these com- 
pounds could act as chemical 
transmitters at parasympathetic 
and sympathetic synapses respec- 
tively. These prescient ideas at- 
tracted little support at the time, 
but were subsequently energetic- 
ally taken up by Dale. Impressed 
by Hunt and Taveau’s demon- 
strationl’ (in 1911) that the acetyl- 
ation of choline enormously 
potentiated its ability to lower 
blood pressure in the cat, Dale 
demonstrated, with Dudley, the 
presence of acet$choline in a 
mammalian tissue . 
However, the identification of 
acetylcholine as the parasym- 
pathetic transmitter, ‘vagusstoff’, 
eluded Dale, and was achieved by 
Otto Loewi (see Ref. 13). Dale and 
Loewi shared the Nobel Prize, and 
Dale and his co-workers identi- 
fied acetylcholine as the trans- 
mitter at a variety of sites, in- 
cluding the electromotor terminals 
of Torpedo, during the 1930s. 
New words often have an 
important slogan value in science. 
Who -would now remember Funk 
if it were not for ‘vitamins’ or 
Benda if it were not for ‘mito- 
chondria’? Dale’s terms adren- 
ergic and cholinergic, while not 
completely accurate, neatly en- 
shrine the concept of chemical 
transmission and have led to an 
extended and progressively less 
euphonious terminology: ‘GABA- 
ergic’, ‘glutamergic’, ‘substance 
P-ergic’, and so on. 
The anticholinesterases 
An important cont~bu~on of 
Otto Loewi was his discovery that 
released acetyicholine is unstable 
in contact with tissues owing to 
the action of a specific enzyme. 
This enzyme, cholinesterase, was 
purified by a husband and wife 
team of Edinburgh biochemists, 
E. and E. Stedman. 
Pfiysostigmine 
Cholinesterase is inhibited by 
the naturally occurring alkaloid 
physostigmine or eserine, a carba- 
mate ester of a nitrogenous base. 
Many synthetic analogues are 
known. 
Loewi’s realization that the 
basic effects of eserinc? were explic- 
able on the basis of its specific 
inhibition of cholinesterase and 
the ensuing accumulation of 
ace~lcholine is perhaps the first 
example of what Sir Rudolph 
Peters termed a ‘biochemical 
lesion‘ - the explanation of a toxic 
action in terms of a specific inter- 
ference with a biochemical mech- 
anism rather than a non-specific, 
generalized effect on the cell. 
The organophosphates 
An even more potent class of 
anticholinesterases is the highly 
toxic organophosphorus com- 
pounds14. These have given 
perhaps the biggest boost of any 
drug or toxin to cholinergic re- 
search because of their potential 
as chemical warfare agents and 
later as insecticides. During World 
War II it became an urgent matter 
of national security for govern- 
ments to know as much as poss- 
ible about the action of these 
substances and how they could be 
combated, and this in turn made it 
essential to understand as fully as 
possible the biochemistry of the 
cholinergic system. The continued 
use of some of these compounds 
as insecticides after the war 
created a record in terms of indus- 
trial toxicology, surpassing even 
the problems that arose when 
tetraethyl lead was introduced as 
an anti-knock agent into petrol by 
the American petroleum chemist 
Kettering in the 1920s. 
The potential of the organo- 
phosphorus anticholinesterases 
was first appreciated in Germany 
between the wars. The first com- 
pound of this type (tetraethyl- 
pyrophosphate, TEPP) was syn- 
thesized as far back as 1854 by De 
Clerrnont. Several other chemists 
worked with this or similar com- 
pocnds but failed to appreciate 
their highly toxic nature. Willy 
Lange and his graduate student 
Gerda von Krueger synthesized 
dimethyl- and diethylphosphoro- 
fluoridate - the first fluorine com- 
pounds in the series - in 1932. 
Thgy immediately appreciated the 
toxicity of these compounds 
(perhaps because they were more 
volatile than TEPP) and noticed 
the effect of the vapour on respira- 
tion and the eyes. Lange was 
interested in synthetic insecti- 
cides and thought his compounds 
might be useful there. It is now 
known that all these effects are 
due to the powerful action of the 
compounds on the cholinergic 
synapse, and that insects use 
cholinergic transmission inten- 
sively in their nervous system. 
Some years later IG Farben- 
industrie put the chemist Gerhard 
Schrader on to making Lange’s 
compounds and many others in 
the Same series - about 2000 be- 
tween 1938 and 1944. Their high 
toxicity interested the German 
Amy7 and a security veil fell on 
the work. About 10000 tons of 
tabun, a cyanide analogue, were 
manufactured in Diihemfurt 
north of Breslau (now Wroclaw) 
in Silesia, the;, part nf the German 
Reich. This factory was captured 
by the Russians and may well 
have been the starting point for 
their interest in chemical warfare. 
The general fornmla of organo- 
phosphorus compounds is given 
in Table II. The group Y is always 
oxygen or sulphur; group X is a 
leaving group which can exist as a 
stable anion. R1 and R2 are alkyl, 
alkoxy, or alkylamino groups. The 
whole molecule acts as a ‘pseudo- 
substrate’ for cholinesterases, 
whose active centre catalyses the 
splitting off of the leaving group 
and the transfer of the rest of the 
molecule to the active site forming 
a stable complex (Fig. 3, Eqn 3). 
Meanwhile, a team of chemists 
and pharmacologists in Britain 
were investigating the literature 
for potential war gases. Prominent 
members were B. C. Saunders15, a 
Cambridge organic chemist, and 
the Kilbys’“, also working in 
Cambridge as a husband and wife 
team, a biochemist and pharma- 
cologist, respectively. In 1940 they 
came across Lange and Krueger’s 
compounds and synthesized and 
tested numerous analogues of 




This team quickly discovered that 
these compounds worked by 
blocking cholinesterase irrever- 
sibly at very low concentrations. 
The more volatile ones were easily 
absorbed by inhalation. 
When the USA entered the war, 
information was passed by the 
British to them and they set up 
their own teams, one of which 
was headed by David Nachman- 
sohn who was one of the few 
biochemists in the USA at that 
time who knew much about 
cholinesterases. 
After the war, the insecticidal 
aspect of the organophospho~s 
compounds began to be worked 
on. The goal was non-volatile com- 
pounds that could be more safely 
handled by farm workers. These 
include mipafox and parathion 
(Table II). 
The combination of continuing 
military and agricultural interest 
in these compounds meant good 
funding for basic research in the 
cholinesterase field and the mode 
of action was fairly quickly dis- 
covered. Kinetic and specificity 
studies by Zeller and BisseggerX7 
and by myself and David Adams”, 
1 carboxylate sters (e.g. acetylcholine) 
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Fig. 3. Kinetics of inleracrion of cholineslerase (E!H) with (1) substratr. (2) carbamale 
anlichollnesterases and (3) organophos@orus compounds. The slability of rhe enzyme 
intermediale determines whether the &and is a subsfrate or inhibitor. 
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and studies of the effect of pH on 
the binding of reversible anti- 
cholinesterases in the enzyme by 
Wilson in Nachmansoh&l’s group 
independency led both US and 
Wilson” to the conclusion that the 
active centre of cholinesterase con- 
sisted of two parts: the acyl bind- 
ing centre, and the ‘negative ni- 
trogen attracting group’ or anionic 
centre which binds the choline 
group of acetyicholine. Work by 
Wilson ef al. and several other 
groups showed that the substrate 
reacted with the acyl active centre 
of the enzyme as an acetylating 
agent to form an acetylated 
enzyme that was then extremely 
rapidly hydrolysed (Fig. 3, Eqn 1). 
The omanonhosphates are oseudo- 
substrates *which transfe; a di- 
alkylphosphate instead of an 
acetate group to the enzyme (see 
above); this is only very slowly 
regenerated by water but can be 
much more rapidly activated by 
substituted hydroxylamines (Fig. 
3, Eqn 3). 
A serious problem in providing 
an effective chemical antidote 
for organophosphorus anticholin- 
esterases is the ‘aging’ reaction 
in which the di~ky~phospho~l- 
or di~kylphosphonyl-esterase is 
slowly converted into a mono- 
alkylphosphoryl- or monoalkyl- 
phosphonyl-esterase. Such link- 
ages are much more difficult to 
reverse (hence the term ‘aging’), 
/==T I /\ / \+/““s 
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fig. 4. Structuri? of naphthymethyl- 
and with some organophosphorus 
anticholinesterases the ‘aged’ state 
is reached in minutes, giving little 
time for chemical therapy. 
In the Case of the carbamate anti- 
cholinesterases, such as physostig- 
mine (eserine) (Fig. 4, Eqn 21, 
the carbamylated enzyme inter- 
mediate is hydrolysed much more 
rapidly by water than the corres- 
ponding phosphorylated enzyme. 
Thus spontaneous reactivation 
occurs in a few hours. 
Blockers of acetylcholine 
synthesis and storage 
Aziridinium compounds 
The choline transporter is very 
sensitive to nitrogen mustard ana- 
logues of choline. These contain 
the three-membered aziridinium 
ring and are alkylating agents. 
They are formed spontaneously in 
solution from the corresponding 
N-chio~methyl tertiary bases. 
Choline analogues of this type 
have a selective affinity for high 
affinity choline binding sites 
which they can be induced to alkyl- 
ate; this blocks the function of the 
choline transporter, eventually 
bringing ace~lcholine synthesis 
to a standstill and blocking trans- 
mission. If the aziridinium com- 
pound is labelled, this also pro- 
vides a handle for isolating the 
transporter protein. The first such 
compound, hemichohnium-3, was 
discovered by SchuelerzO in 1955. 
Radioactive hemicho!inium and 
a simpler compound, choline 
mustard aziridinium, have been 
used by BreerZ1 and by RyletP, 
respectively, to isolate the choline 
transporter from insect brain and 
Torpedo electromotor terminals. 
The insect carrier appears to be a 
single peptide of relative mol- 
ecular mass 86 000, and the Torpedo 
carrier a complex of two peptides 
of 43000 and 57000. 
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Choline acetyltrunsferase 
inhibitors 
The anti-ChAT compound 
naphthylmethylpyridinium (Fig. 
4) was introduced by Cavallito23 
in 1962. Its lack of specificity has, 
however, limited its use. 
Vesamicol 
This inhibitor of vesicular 
acetylcholine uptake (also known 
as AH-5183) was discovered by 
MarshalP, but its mode of action 
was defined by Stanley Parsons? 
who has shown that it blocks the 
uptake of acetylcholine into the 
recycling vesicles which are in- 
volved in transmitter release (Fig. 
1). Such vesicles are recruited on 
stimulation from the reserve pool 
and their discovery has gone far to 
resolve some of the paradoxes of 
the vesicular theory of transmitter 
storage and releasez6,“. 
E3 •I cl 
There is little doubt that new 
drugs and toxins will continue to 
provide a powerful tool for dissect- 
ing and understanding cholin- 
ergic and other types of synaptic 
function. 
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of classificatio 
and structure 
Jack Peter Green 
In an attempt to contain the chaos of receptor nomenclature, the supplement 
distributed with this issue of TiPS catalogues cell surface receptors and their 
subtypes according to the most commoniy used nomenclature and describes 
them in pha~acological, biochemical and molecular terms. This reposing of 
the status quo will be an invazuable aid to communication, but ali scientists 
(not just pharmacologists) working on receptors would agree that a radical and 
rational classification of receptors also needs to be initiated. In this article, Jack 
Peter Green Froposes a system of (and mechanism for) classification that 
should satisfy both the ‘taxonomic realists’ and fhe ‘taxonomic skeptics’. 
In considering receptor classi- 
fication and nomenclature, it is 
advantageous to learn from the 
taxonomies that have evolved for 
other entities. There is no 
shortage of examples, some of 
which go back at least to the time 
of Aristotle’~*. Classification has 
been a preoccupation throughout 
history and is perhaps an expres- 
sion of the human eagerness to 
divide things into specific cat- 
egories and to give them names - 
an essential for communication. 
Few things have avoided classi- 
fication and naminc*. Systems 
have been developed for organ- 
isms (including viruses), antigens, 
enzymes, organic chemicals 
according to their structures, 
diseases, personality variants, the 
physical status of patients (e.g. 
1. P. Gee*: is Professor and Chair, Deparf- 
ment of Pharmacology, Mount Sinai School of 
Medicine of the City University of New York, 
NY 10029, USA. 
after surgery, or rankings of the 
severity of a disease, as in Parkin- 
son’s disease), languages, stars, 
and so on. Official classifications 
are almost always establish 1 
under the aegis of the appropriate 
professional societies. 
Classifications that evolve 
haphazardly tend to be far less 
orderly, producing classes that 
may be unparallel and unrelated. 
For example, the classification 
system for drugs is not logical or 
consistent, as is demonstrated by 
a list of the chapter headings in 
any textbook of pharmacology. 
In a randomly selected typical 
textbook, drugs are classified 
according to the sites and types of 
action (e.g. Cholinergic agonists), 
the gross effects (e.g. Sedatives 
and hypnotics), the disease5 they 
are used to treat {e.g Drugs used 
in gout), a discipline (Toxicology), 
the signs, symptoms, or syn- 
dromes they are used for (e.g. 
Antihypertensive agents, Anti- 
arrhythmic agents), the processes 
they are used to alter (e.g. Anti- 
coagulants, Diuretics), and com- 
binations of qualities (e.g. Cardiac 
glycosides, an imprecisely defined 
chemical grouping used for an 
effect on a specific organ). Sub- 
divisions of a chapter on drugs 
acting on the CNS might include: 
General anesthetics (a title based 
on use); Aliphatic alcohols (a title 
based on chemical structure); and 
Drug addiction and drug abuse (a 
title based on a special response). 
Mowever inconsistent this 
classification, it serves because 
the reader knows what infor- 
mation is encompassed in a uis- 
cussion of each class of drug. 
Sometimes, however, classifi- 
cations and names offered by 
individuals can so vary that con- 
fusion results, a circumstance that 
provoked publication of Enzyme 
Nomenclature5 and that now 
fosters the need for an official 
classification and naming of 
receptor5-.4P”. As research on re- 
ceptors continues, it is likely that 
different names of receptors and 
different schemes of classification 
will continue to increase, reflect- 
ing the different interests and 
research goals of scientists. The 
confusion could exceed that which 
engendered Enzyme ~omenclafurc 
since scientists working on recep- 
tors come from disparate disci- 
plines using different techniques, 
whereas enzymologists comprise 
a comparatively cohesive group. 
Realists and skeptics 
Classifiers have been divided 
into two groups7: the taxonomic 
realists and taxonomic skeptics. 
The realists assume that a par- 
ticular taxonomy is correct or in- 
correct, that objects are ordered 
into natural groups. The taxo- 
nomic skeptics judge a taxonomy 
by its usefulness, which depends 
on the purposes of the classifi- 
cation. The skeptics would be less 
disturbed than the realists by the 
view that classification schemes 
